Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meldonium capsules in ischemic heart disease
CTR20132170Phase 2Completed
- Sponsor
- Shandong Chengchuang Pharmaceutical Technology Development
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of meldonium in coronary arteriosclerosis, sponsored by Shandong Chengchuang Pharmaceutical Technology Development. Started Apr 2014; status: completed.
02
Drugs
meldonium
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on CTR20132170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132170.